Fund+

Fund+ is a prominent Belgian evergreen venture capital fund headquartered in Leuven, specializing in the European life sciences sector. Established in 2015, the fund was initiated with significant backing from the Belgian Federal Government, through the Federal Holding and Investment Company (SFPI-FPIM), alongside other institutional and private investors. Its core mission is to foster innovation within diagnostics, therapeutics, medical devices, and broader life sciences tools and services, aiming to address critical health challenges and advance medical breakthroughs.

The fund targets early-stage and growth-stage companies that demonstrate robust scientific foundations and substantial market potential. Fund+ is known for its hands-on approach, providing not just capital but also strategic guidance to its portfolio companies. Typically, Fund+ deploys initial investments ranging from approximately $1.08 million (€1 million) up to $16.2 million (€15 million) per company. This flexible investment range allows them to support a diverse set of ventures, from nascent startups to more mature enterprises seeking scale-up capital.

As an evergreen fund, Fund+ benefits from an indefinite investment horizon, enabling a long-term perspective on its portfolio companies' development and potential for value creation. This structure allows for patient capital deployment, which is particularly crucial in the often lengthy development cycles characteristic of the life sciences industry. The fund commenced operations with an initial capital commitment of approximately $216 million (€200 million), underscoring its significant financial capacity to support groundbreaking innovations across Europe.